BCAL Diagnostics Limited (AU:BDX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BCAL Diagnostics Limited (BDX) has requested an immediate voluntary suspension of its shares from trading on the Australian Securities Exchange, pending an upcoming announcement about the company’s capital raising efforts. The suspension is to allow additional time for finalizing the capital raise bookbuild and is expected to last until either the announcement is made or June 3, 2024.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.